Menu
GeneBe

IL4R

interleukin 4 receptor, the group of CD molecules|Interleukin receptors

Basic information

Region (hg38): 16:27313667-27364778

Links

ENSG00000077238NCBI:3566OMIM:147781HGNC:6015Uniprot:P24394AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • IgE responsiveness, atopic (No Known Disease Relationship), mode of inheritance: Unknown

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the IL4R gene.

  • Inborn genetic diseases (29 variants)
  • not provided (14 variants)
  • IgE responsiveness, atopic;Susceptibility to HIV infection (2 variants)
  • IL4R-related condition (1 variants)
  • IgE responsiveness, atopic (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the IL4R gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
1
clinvar
4
clinvar
5
missense
28
clinvar
4
clinvar
4
clinvar
36
nonsense
0
start loss
0
frameshift
0
inframe indel
0
splice donor/acceptor (+/-2bp)
0
splice region
1
1
non coding
1
clinvar
1
clinvar
2
Total 0 0 28 6 9

Variants in IL4R

This is a list of pathogenic ClinVar variants found in the IL4R region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
16-27342158-C-T IL4R-related disorder Benign (Dec 19, 2019)771761
16-27342183-G-A not specified Uncertain significance (Dec 19, 2023)3109439
16-27342184-A-G IgE responsiveness, atopic Uncertain significance (Feb 07, 2022)2442131
16-27342219-G-A not specified Uncertain significance (Jan 24, 2023)2457376
16-27342225-C-T not specified Uncertain significance (Jul 09, 2021)2361862
16-27342268-G-C Benign (Jun 18, 2018)781201
16-27344882-A-G Atopy, resistance to Benign (Oct 01, 2005)14666
16-27344896-C-T Benign (Aug 14, 2018)718605
16-27344903-G-A IL4R-related disorder Benign (Aug 21, 2019)3043783
16-27344904-C-T not specified Likely benign (Jan 30, 2024)3109448
16-27344950-T-C Benign (Aug 14, 2018)778606
16-27345014-G-A not specified Uncertain significance (Oct 06, 2021)2360543
16-27346475-A-G not specified Uncertain significance (May 05, 2023)2544207
16-27346542-C-T not specified Uncertain significance (Jan 08, 2024)3109449
16-27346601-G-C not specified Uncertain significance (Sep 16, 2021)2249995
16-27352546-A-G not specified Likely benign (Nov 09, 2023)3109450
16-27352621-G-A not specified Uncertain significance (Oct 05, 2021)2253102
16-27352627-G-A not specified Uncertain significance (Sep 14, 2022)2224161
16-27352674-C-A not specified Uncertain significance (Dec 07, 2021)2265949
16-27355824-C-G not specified Likely benign (Feb 23, 2023)2488041
16-27355825-G-A not specified Uncertain significance (Feb 26, 2024)3109451
16-27355905-C-G Benign (Dec 31, 2019)768763
16-27358957-G-A IL4R-related disorder Benign (Mar 20, 2020)708028
16-27358962-C-T not specified Uncertain significance (Feb 06, 2023)2480869
16-27358963-G-A not specified Likely benign (Feb 17, 2022)2277811

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
IL4Rprotein_codingprotein_codingENST00000395762 951111
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.0002300.9821257290181257470.0000716
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense0.7694284750.9010.00002605368
Missense in Polyphen75100.980.742721234
Synonymous0.2422002040.9780.00001261671
Loss of Function2.11918.90.4779.06e-7194

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0001810.000181
Ashkenazi Jewish0.000.00
East Asian0.0001090.000109
Finnish0.000.00
European (Non-Finnish)0.00008800.0000879
Middle Eastern0.0001090.000109
South Asian0.00006530.0000653
Other0.000.00

dbNSFP

Source: dbNSFP

Function
FUNCTION: Receptor for both interleukin 4 and interleukin 13. Couples to the JAK1/2/3-STAT6 pathway. The IL4 response is involved in promoting Th2 differentiation. The IL4/IL13 responses are involved in regulating IgE production and, chemokine and mucus production at sites of allergic inflammation. In certain cell types, can signal through activation of insulin receptor substrates, IRS1/IRS2. {ECO:0000269|PubMed:8124718}.;
Pathway
PI3K-Akt signaling pathway - Homo sapiens (human);Jak-STAT signaling pathway - Homo sapiens (human);Inflammatory bowel disease (IBD) - Homo sapiens (human);Th17 cell differentiation - Homo sapiens (human);Th1 and Th2 cell differentiation - Homo sapiens (human);Pathways in cancer - Homo sapiens (human);Hematopoietic cell lineage - Homo sapiens (human);Cytokine-cytokine receptor interaction - Homo sapiens (human);JAK-STAT-Core;IL-4 Signaling Pathway;Focal Adhesion-PI3K-Akt-mTOR-signaling pathway;Interleukin-4 and 13 signaling;PI3K-Akt Signaling Pathway;Inflammatory Response Pathway;Interleukin-4 and 13 signaling;Signaling by Interleukins;il 4 signaling pathway;Cytokine Signaling in Immune system;JAK STAT MolecularVariation 1;Immune System;p73 transcription factor network;IL-4 signaling;JAK STAT MolecularVariation 2;JAK STAT pathway and regulation;IL4;IL4-mediated signaling events;IL-13 signaling (Consensus)

Recessive Scores

pRec
0.571

Intolerance Scores

loftool
0.562
rvis_EVS
1.21
rvis_percentile_EVS
93.05

Haploinsufficiency Scores

pHI
0.181
hipred
Y
hipred_score
0.542
ghis
0.432

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.986

Gene Damage Prediction

AllRecessiveDominant
MendelianHighHighHigh
Primary ImmunodeficiencyHighHighHigh
CancerHighHighHigh

Mouse Genome Informatics

Gene name
Il4ra
Phenotype
nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); digestive/alimentary phenotype; immune system phenotype; liver/biliary system phenotype; respiratory system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); hematopoietic system phenotype; endocrine/exocrine gland phenotype; cellular phenotype; homeostasis/metabolism phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); growth/size/body region phenotype;

Gene ontology

Biological process
production of molecular mediator involved in inflammatory response;positive regulation of immunoglobulin production;immune response;signal transduction;immunoglobulin mediated immune response;cytokine-mediated signaling pathway;ovulation;interleukin-4-mediated signaling pathway;regulation of cell population proliferation;defense response to protozoan;positive regulation of macrophage activation;positive regulation of mast cell degranulation;response to estrogen;negative regulation of T-helper 1 cell differentiation;positive regulation of T-helper 2 cell differentiation;positive regulation of chemokine secretion;positive regulation of cold-induced thermogenesis;positive regulation of myoblast fusion;response to odorant
Cellular component
extracellular space;plasma membrane;integral component of plasma membrane;receptor complex
Molecular function
interleukin-4 receptor activity;protein binding